PLEK2 and non-small cell lung carcinoma: A study reported that PLEK2 was highly expressed in non-small cell lung cancer cells and promoted EMT, EndoMT, vascular endothelial barrier disruption, and tumor metastasis, suggesting the role of PLEK2 in tumor metastasis (13).